Germany : Lonza Acquires Stake in Cilian AG.Byline: deepak03 Lonza announced today that it has signed an investment agreement, including a right of first refusal Right of First Refusal In general, the right of a person or company to purchase something before the offering is made available to others. Notes: For example, a football team may have the right of first refusal on a player's contract. for the commercial production of products, with Cilian AG. The collaboration with Cilian provides access to a prospective technology platform for innovative applications in the nutrition and biopharmaceutical area. Cilian AG is a small innovative biotechnology company which uses the abilities of ciliates, eukaryotic eukaryotic /eu·kary·ot·ic/ (u?kar-e-ot´ik) pertaining to a eukaryon or to a eukaryote. eukaryotic pertaining to eukaryosis. eukaryotic cells see cell. single-cell micro-organisms (specifically the strain Tetrahymena tetrahymena free-living, freshwater ciliate sometimes capable of infecting and causing disease in fish. thermophila), for the production of therapeutic proteins and nutritional ingredients. Lonza owns a number of patents and patent applications in the field of Tetrahymena thermophila and will transfer these patents and patent applications to Cilian. In return Lonza will acquire newly issued shares in Cilian AG together with the right of first refusal for the commercial production of products developed by Cilian based on the patent portfolio of Lonza. Remco M. Brandt, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Cilian AG, said: We are extremely pleased with the participation of Lonza in Cilian. Their input allows us to leverage the value of Cilian by building our own product pipeline using the unique Ciliate ciliate /cil·i·ate/ (sil´e-at) 1. having cilia. 2. any individual of the Ciliophora. cil·i·ate n. Any of various protozoans of the class Ciliata. adj. production platform . We believe that Cilian s production platform for enzymes Enzymes Organic substances (proteins) composed of amino acids that trigger and regulate chemical reactions in the body. There are over 700 identified human enzymes. Mentioned in: Interactions, Nutritional Supplements , antibodies and other proteins has the potential to provide attractive innovations in the nutrition and biopharmaceutical area , says Thomas Kiy, Global Head Strategic Business Development of Lonza Life Science Ingredients. Copyright : Euclid Infotech Pvt. Ltd. Provided by Syndigate.info an Albawaba.com company |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion